A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.

Clinical trial NCT00475423 · COMPLETED

Trial details

NCT number: NCT00475423
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Thrombocytopenic Purpura

Start date: 2007-05-01
Primary completion: 2011-08-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.